Skip to main content
Livermore
Livermore
ZHEN

Searle & Co.

SEC CIK
0000710127
Latest filing
Jul 27, 2026

HRTX holding history

Heron Therapeutics, Inc. in every 13F filed by Searle & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings

Shares (Q2 2026)
86,250
Value
$36.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HRTX by Searle & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202686,250$36.8K<0.1%00.0%UnchangedHolders
Q1 202686,250$69.0K<0.1%00.0%UnchangedHolders
Q4 202586,250$112.1K<0.1%00.0%UnchangedHolders
Q3 202586,250$108.7K<0.1%00.0%UnchangedHolders
Q2 202586,250$178.5K0.1%00.0%UnchangedHolders
Q1 202586,250$189.8K0.1%00.0%UnchangedHolders
Q4 202486,250$132.0K<0.1%00.0%UnchangedHolders
Q3 202486,250$171.6K<0.1%+75,250+684.1%AddedHolders
Q2 202411,000$38.5K<0.1%−75,250−87.2%ReducedHolders
Q1 202486,250$238.9K0.1%+1,000+1.2%AddedHolders
Q4 202385,250$144.9K<0.1%00.0%UnchangedHolders
Q3 202385,250$87.8K<0.1%+7,000+8.9%AddedHolders
Q2 202378,250$129.9K<0.1%+15,000+23.7%AddedHolders
Q1 202363,250$151.2K<0.1%+30,000+90.2%AddedHolders
Q4 202233,250$83.1K<0.1%00.0%UnchangedHolders
Q3 202233,250$140.0K0.1%00.0%UnchangedHolders
Q2 202233,250$93.0K<0.1%00.0%UnchangedHolders
Q1 202233,250$190.0K0.1%−14,500−30.4%ReducedHolders
Q4 202147,750$436.0K0.2%00.0%UnchangedHolders
Q3 202147,750$510.0K0.2%+500+1.1%AddedHolders
Q2 202147,250$733.0K0.3%+10,000+26.8%AddedHolders
Q1 202137,250$604.0K0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.